BIO Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Biotest AG

Watchlist Manager

Watchlist

Price: 42.6 EUR Market Closed

Market Cap: €1.7B

B	Biotest AG XBER:BIO	DE
M	Monolithic Power Systems Inc F:NQG	US
S	Shurgard Self Storage Ltd F:S8V	GG
U	Unity Software Inc F:US3	US
	Property Franchise Group PLC LSE:TPFG	UK
K	Keppel Corporation Ltd DUS:KEP1	SG
	Dynavax Technologies Corp NASDAQ:DVAX	US
D	Deutsche Post AG XMUN:DHL	DE
I	InPlay Oil Corp SWB:8DA1	CA
C	Clover Health Investments Corp F:7QD	US
	Bank of Jiangsu Co Ltd SSE:600919	CN
D	Diamondback Energy Inc SWB:7DB	US
F	FFI Holdings Ltd ASX:FFI	AU

Profitability Summary

Biotest AG's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

23%

Sustainable 3Y Average Gross Margin

34%

Gross Margin is Increasing

22% > 23%

Low Operating Margin

Sustainable 3Y Average Operating Margin

13%

Operating Margin is Increasing

-3% > 2%

Negative Net Margin

-4%

Low 3Y Average Net Margin

Net Margin is Increasing

-8% > -4%

Healthy Free Cash Flow Margin

Negative 3Y Average Free Cash Flow Margin

-1%

Free Cash Flow Margin is Increasing

-23% > 2%

Negative ROE

-5%

Positive 3Y Average ROE

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.